Table of Content

1 Research Methodology
2 Research Objectives
3 Research Process

4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope Of The Study
4.4 Market Segments
4.4.1 Market Segmentation By Indication
4.4.2 Market Segmentation By Drug Type
4.4.3 Market Segmentation By End-User
4.4.4 Market Segmentation By Geography

5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation

6 Market at a Glance
7 Introduction
7.1 Drug Coated Balloons (DCBS): An Overview
7.1.1 Background
7.1.2 Use Of DCBS

8 Market Opportunities & Trends
8.1 Increased Application Of DCBS To Treat Medical Disorders
8.2 Promising Investigational Drug-Coated Balloons
8.3 Emergence Of New Generation DCBS

9 Market Growth Enablers
9.1 Global Increase In Target Patient Pool
9.2 Increasing Demand For DCBS Due To Promosing Outcomes
9.3 Increased Focus On Generating Abundant Clinical Data
9.4 New Product Approvals/Launches

10 Market Restraints
10.1 Presence Ofalternative Treatment Procedures
10.2 Stringency In Regulatory Approvals
10.3 Lack Of Reimbursement Coverage For DCBS

11 Market Landscape
11.1 Market Overview
11.2 Covid-19 Impact On Global Drug-Coated Balloons Market
11.3 Market Size & Forecast
11.3.1 Geographic Insights
11.3.2 Indication Insights
11.3.3 Drug Type
11.3.4 End-User Insights
11.4 Five Forces Analysis
11.4.1 Threat Of New Entrants
11.4.2 Bargaining Power Of Suppliers
11.4.3 Bargaining Power Of Buyers
11.4.4 Threat Of Substitutes
11.4.5 Competitive Rivalry

12 Indication
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 PAD
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.4 CAD
12.4.1 Market Overview
12.4.2 Market Size & Forecast
12.5 Others
12.5.1 Market Overview
12.5.2 Market Size & Forecast

13 Drug Type
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Paclitaxel
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.4 Sirolimus
13.4.1 Market Overview
13.4.2 Market Size & Forecast

14 End-User
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Hospitals
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.4 Freestanding Cath Labs
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.5 ASCS
14.5.1 Market Overview
14.5.2 Market Size & Forecast

15 Geography
15.1 Market Snapshot & Growth Engine
15.2 Geographic Overview

16 North America
16.1 Market Overview
16.2 Market Size & Forecast
16.3 Key Countries
16.3.1 US: Market Size & Forecast
16.3.2 Canada: Market Size & Forecast

17 Europe
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Key Countries
17.3.1 Germany: Market Size & Forecast
17.3.2 France: Market Size & Forecast
17.3.3 UK: Market Size & Forecast
17.3.4 Italy: Market Size & Forecast
17.3.5 Spain: Market Size & Forecast

18 APAC
18.1 Market Overview
18.2 Market Size & Forecast
18.4 Key Countries
18.4.1 Japan: Market Size & Forecast
18.4.2 China: Market Size & Forecast
18.4.3 Australia: Market Size & Forecast
18.4.4 South Korea: Market Size & Forecast
18.4.5 India: Market Size & Forecast

19 Latin America
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Key Countries
19.3.1 Brazil: Market Size & Forecast
19.3.2 Mexico: Market Size & Forecast
19.3.3 Argentina: Market Size & Forecast

20 Middle East & Africa
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Key Countries
20.3.1 Turkey: Market Size & Forecast
20.3.2 Saudi Arabia: Market Size & Forecast
20.3.3 Israel: Market Size & Forecast
20.3.4 South Africa: Market Size & Forecast

21 Competitive Landscape
21.1 Competition Overview
21.2 Market Share Analysis
21.2.1 Medtronic
21.2.2 BD
21.2.3 Koninklijke Philips
21.2.4 Boston Scientific
21.2.5 B. Braun Melsungen

22 Key Company Profiles
22.1 Medtronic
22.1.1 Business Overview
22.1.2 Product Offerings
22.1.3 Key Strategies
22.1.4 Key Strengths
22.1.5 Key Opportunities
22.2 BD
22.2.1 Business Overview
22.2.2 Product Offerings
22.2.3 Key Strategies
22.2.4 Key Strengths
22.2.5 Key Opportunities
22.3 Koninklijke Philips
22.3.1 Business Overview
22.3.2 Product Offerings
22.3.3 Key Strategies
22.3.4 Key Strengths
22.3.5 Key Opportunities
22.4 Boston Scientific
22.4.1 Business Overview
22.4.2 Product Offerings
22.4.3 Key Strategies
22.4.4 Key Strengths
22.4.5 Key Opportunities
22.5 B. Braun Melsungen
22.5.1 Business Overview
22.5.2 Product Offerings
22.5.3 Key Strategies
22.5.4 Key Strengths
22.5.5 Key Opportunities

23 Other Prominent Vendors
23.1 Aachen Resonance
23.1.1 Business Overview
23.1.2 Product Offerings
23.2 Acotec Scientific
23.2.1 Business Overview
23.2.2 Product Offerings
23.3 Ar Baltic Medical
23.3.1 Business Overview
23.3.2 Product Offerings
23.4 Biosensors International Group
23.4.1 Business Overview
23.4.2 Product Offerings
23.5 Biotronik
23.5.1 Business Overview
23.5.2 Product Offerings
23.6 Cardionovum
23.6.1 Business Overview
23.6.2 Product Offerings
23.7 Concept Medical
23.7.1 Business Overview
23.7.2 Product Offerings
23.8 Eucatech
23.8.1 Business Overview
23.8.2 Product Offerings
23.9 Endocor
23.9.1 Business Overview
23.9.2 Product Offerings
23.10 Hexacath
23.10.1 Business Overview
23.10.2 Product Offerings
23.11 Ivascular
23.11.1 Business Overview
23.11.2 Product Offerings
23.12 M.A. Med Alliance
23.12.1 Business Overview
23.12.2 Product Offerings
23.13 Meril Life Sciences
23.13.1 Business Overview
23.13.2 Product Offerings
23.14 Nano Therapeutics
23.14.1 Business Overview
23.14.2 Product Offerings
23.15 QT Vascular
23.15.1 Business Overview
23.15.2 Product Offerings
23.16 Rd Global-Invamed
23.16.1 Business Overview
23.16.2 Product Offerings
23.17 Stentys
23.17.1 Business Overview
23.17.2 Product Offerings
23.18 Surmodics
23.18.1 Business Overview
23.18.2 Product Offerings
23.19 Terumo
23.19.1 Business Overview
23.19.2 Product Offerings
23.20 Urotronic
23.20.1 Business Overview
23.20.2 Product Offerings
23.21 Wellinq
23.21.1 Business Overview
23.21.2 Product Offerings

24 Investigational Companies
24.1 Micell Technologies
24.1.1 Business Overview
24.1.2 Investigational Products
24.2 Orchestra Biomed
24.2.1 Business Overview
24.2.2 Investigational Products

25 Report Summary
25.1 Key Takeaways
25.2 Strategic Recommendations

26 Quantitative Summary
26.1 Indication
26.2 Drug Type
26.3 End-User
26.4 Geography

27 Appendix
27.1 Abbreviations